Company | Date | Price Target | Rating | Analyst |
---|---|---|---|---|
9/16/2024 | $16.00 | Neutral → Buy | Ladenburg Thalmann | |
4/29/2024 | Buy → Neutral | Ladenburg Thalmann | ||
3/1/2024 | $14.00 | Mkt Outperform | JMP Securities | |
12/15/2023 | $17.00 → $12.00 | Buy | Jefferies | |
10/5/2023 | Buy | Maxim Group | ||
6/2/2023 | $25.00 | Outperform | Oppenheimer | |
5/8/2023 | $25.00 | Outperform | BMO Capital Markets | |
4/27/2023 | $22.00 | Buy | Ladenburg Thalmann |
Ladenburg Thalmann upgraded Acrivon Therapeutics from Neutral to Buy and set a new price target of $16.00
Ladenburg Thalmann downgraded Acrivon Therapeutics from Buy to Neutral
JMP Securities initiated coverage of Acrivon Therapeutics with a rating of Mkt Outperform and set a new price target of $14.00
Governor Ron DeSantis went there at the Republican National Convention (RNC) in Milwaukee on Wednesday: He used his platform to rail against Florida's upcoming vote to legalize recreational marijuana telling his comrades that if weed is legalized, people will be able to possess practically limitless amounts of the stuff. "It gives you a limitless constitutional right to possess and smoke. I think it's up to like, what, 40 joints, is that the three ounces would be 40? More than that, 80 joints. Something like that," he said. In fact, he noted that if the cannabis legalization ballot wins, marijuana rights will surpass the constitutional guarantees of the First and Second Amendments
ORLANDO, FL / ACCESSWIRE / August 29, 2024 / Laser Photonics Corporation (NASDAQ:LASE), ("LPC"), a leading global developer of CleanTech laser systems for laser cleaning and other material applications, today announced results for its second quarter ended June 30, 2024.Wayne Tupuola, CEO of Laser Photonics, commented:"While our second quarter reflected a revenue decline due to pushouts in timing for expected orders that were delayed resulting from customers' internal capex review processes, we are encouraged by the mix of CleanTech representing over 80% of our sales during the quarter."Looking ahead, we are focused on market penetration activities for CleanTech, developing and commercializin
Revenue Increased 19% both Sequentially and Year over Year Operating Expenses Decreased 31%, Marking Eight Consecutive Quarters of Year Over Year Improvement Due to Successful Cost Cutting Initiatives Management to Host Conference Call Today at 5:00 pm ET LITTLETON, Colo., Aug. 14, 2024 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. ("Vivos" or the "Company'') (NASDAQ:VVOS), a leading medical device and technology company specializing in the development and commercialization of highly effective proprietary treatments for sleep related breathing disorders (including all severities of obstructive sleep apnea (OSA) in adults), today reported financial results and operating highli
LITTLETON, Colo., Aug. 14, 2024 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. ("Vivos" or the "Company") (NASDAQ:VVOS), a leading medical device and technology company specializing in the development and commercialization of highly effective proprietary treatments for sleep related breathing disorders (including all severities of obstructive sleep apnea (OSA) in adults), today announced it plans to release its second quarter 2024 financial results after market close today, Wednesday, August 14, 2024. Vivos' management will conduct a conference call today at 5:00 p.m. (Eastern Time) to review the results and provide an overview of Vivos' recent achievements and developments. To access Vivo
4 - Laser Photonics Corp (0001807887) (Issuer)
4 - Acrivon Therapeutics, Inc. (0001781174) (Issuer)
4 - Laser Photonics Corp (0001807887) (Issuer)
4 - Acrivon Therapeutics, Inc. (0001781174) (Issuer)
4 - Acrivon Therapeutics, Inc. (0001781174) (Issuer)
SC 13G/A - Acrivon Therapeutics, Inc. (0001781174) (Subject)
SC 13G/A - Acrivon Therapeutics, Inc. (0001781174) (Subject)
SC 13G/A - Acrivon Therapeutics, Inc. (0001781174) (Subject)
Laser Photonics Corporation (LPC) (NASDAQ:LASE), a leading global industrial developer of laser systems for cleaning and other material processing applications, announced today that it will join Brokk, a leading manufacturer of remote-controlled demolition robots, at the 2024 MINExpo INTERNATIONAL – the world's largest mining event. Set to take place from September 24 to 26 in Las Vegas, Nevada, MINExpo covers all phases of mining and attracts buyers from many sectors, including coal, metal and mineral production; equipment manufacturers; and suppliers of goods and services related to mining. The event is hosted by the National Mining Association (NMA), the only national trade association
LPC brings in significant industry sales experience to drive laser cutting technology sales in these new markets Laser Photonics Corporation (NASDAQ:LASE) (LPC), a leading global developer of laser systems for cleaning and other material processing applications, announced today that it has appointed Brady A. Hart as its new Semiconductor and Display Sales Director as part of its long-term growth and diversification strategy. Prior to joining Laser Photonics, Hart served as the Regional Sales Manager for the West Coast at Microtips Technology, a custom LCD display manufacturer, and as Strategic Account Manager for Precision Electronic Glass, a provider of custom glass and quartz products
WATERTOWN, Mass., March 28, 2024 (GLOBE NEWSWIRE) -- Acrivon Therapeutics, Inc. ("Acrivon" or "Acrivon Therapeutics") (NASDAQ:ACRV), a clinical stage biopharmaceutical company developing precision oncology medicines that it matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proprietary proteomics-based patient responder identification platform, Acrivon Predictive Precision Proteomics (AP3), today reported financial results for the fourth quarter and full year ended December 31, 2023 and provided business highlights. "On the heels of a productive 2023, we are off to a tremendous start in 2024, which is an important and data-driven year
Laser Photonics Corporation (LPC) (NASDAQ:LASE), a leading global developer of industrial laser systems for cleaning and other material processing applications, in partnership with its sibling company Fonon Technologies, announced today that it is processing the order for a DefenseTech laser system from the Pearl Harbor Naval Shipyard and Intermediate Maintenance Facility (PHNSY & IMF). LPC is to deliver to PHNSY & IMF the DefenseTech MRLS Portable Finishing Laser 1010 (DTMF-1010) – an ultra-compact and portable pulsed fiber laser system for surface treatment. Designed explicitly for the naval tool kit, the DTMF-1010 is efficient in small-scale de-oxidation and rust control, top-layer coat
Confirmed overall response rate (ORR) = 62.5% (95% CI, 30.4-86.5) observed in prospectively-selected ACR-368 OncoSignature-positive (BM+) patients with endometrial cancer Achieved statistically significant segregation of responders in BM+ vs BM- subgroups based on OncoSignature patient selection (p-value = 0.009) ACR-368 endometrial cohort data maturing with all responders still on therapy; mDoR not yet reached (~6 months at time of data-cut) Endometrial cancer now anticipated to be the first tumor type with potential for ACR-368 accelerated regulatory approval IND clearance and initial sites activated ahead of timelines for ACR-2316 with first-in-human dosing anticipated in Q4 2024 AP3
Laser Photonics Corporation (LPC) (NASDAQ:LASE), a leading global developer of industrial laser systems for cleaning and other material processing applications, announced today that it has completed a sale and is working on a partnership agreement with the U.S. division of Acuren, a leading provider of asset protection services through nondestructive testing (NDT) and consulting. LPC is to deliver its CleanTech Industrial Roughening Laser 3050 (CTIR-3050) to the U.S. Operations of Acuren in a sale that marks the beginning of the two companies' relationship. The two companies are working together to have LPC join Acuren as a preferred partner for an ongoing purchasing program. This collabor
PRE 14C - Laser Photonics Corp (0001807887) (Filer)
8-K - Acrivon Therapeutics, Inc. (0001781174) (Filer)
S-1 - Laser Photonics Corp (0001807887) (Filer)